-+ 0.00%
-+ 0.00%
-+ 0.00%

OnKure Therapeutics shareholders approved amended, restated 2024 equity incentive plan at annual meeting

PUBT·06/04/2026 20:18:11
Listen to the news
OnKure Therapeutics shareholders approved amended, restated 2024 equity incentive plan at annual meeting
  • On June 3, 2026, Onkure Therapeutics held its annual shareholder meeting.
  • Shareholders authorized an amended and restated 2024 equity incentive plan, including a one-time increase of 3,231,638 shares for issuance.
  • The plan changes also removed the annual share cap from the evergreen provision while keeping the annual increase at 5% of outstanding shares.
  • Shareholders ratified KPMG LLP as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onkure Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-257423), on June 04, 2026, and is solely responsible for the information contained therein.